0001285393-24-000003.txt : 20240823 0001285393-24-000003.hdr.sgml : 20240823 20240823101407 ACCESSION NUMBER: 0001285393-24-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20240823 DATE AS OF CHANGE: 20240823 EFFECTIVENESS DATE: 20240823 FILER: COMPANY DATA: COMPANY CONFORMED NAME: D. E. Shaw Oculus Fund, L.L.C. CENTRAL INDEX KEY: 0001285393 ORGANIZATION NAME: IRS NUMBER: 200805158 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-64162 FILM NUMBER: 241234030 BUSINESS ADDRESS: STREET 1: TWO MANHATTAN WEST STREET 2: 375 NINTH AVENUE, 52ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-478-0000 MAIL ADDRESS: STREET 1: TWO MANHATTAN WEST STREET 2: 375 NINTH AVENUE, 52ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: D E SHAW OCULUS FUND LLC DATE OF NAME CHANGE: 20040330 D/A 1 primary_doc.xml X0708 D/A LIVE 0001285393 D. E. Shaw Oculus Fund, L.L.C. TWO MANHATTAN WEST 375 NINTH AVENUE, 52ND FLOOR NEW YORK NY NEW YORK 10001 212-478-0000 DELAWARE D E SHAW OCULUS FUND LLC Limited Liability Company true n/a n/a D. E. Shaw & Co., L.L.C. TWO MANHATTAN WEST 375 NINTH AVENUE, 52ND FLOOR New York NY NEW YORK 10001 Director D. E. Shaw & Co., L.L.C. is the managing member of the issuer. Pooled Investment Fund Hedge Fund false Decline to Disclose 06c 3C 3C.7 true 0001137827-21-000010 2004-07-01 true true false 1000000 D. E. Shaw Securities, L.L.C. 24332 None None TWO MANHATTAN WEST 375 NINTH AVENUE, 52ND FLOOR New York NY NEW YORK 10001 All States true Indefinite 5277288200 Indefinite false 573 0 0 D. E. Shaw Securities, L.L.C. received an upfront placement agent fee of $2,500.00 in connection with this offering. This fee was paid by the issuer's investment adviser and did not reduce Total Amount Sold. 0 false D. E. Shaw Oculus Fund, L.L.C. /s/ Daniel R. Marcus Daniel R. Marcus Authorized Signatory 2024-08-23